Does Kombiglyze Xr Put Patients At Risk Of Heart Failure? From a Nashville Kombiglyze XR Lawyer6/2/2023
If you took Kombiglyze XR and suffered Kombiglyze XR side effects call a Nashville Kombiglyze XR lawyer you may be eligible for a Kombiglyze XR lawsuit
Understanding the link between Kombiglyze XR and heart failure and other Kombiglyze XR side effects is crucial for patients who are taking this medication. Kombiglyze XR is a combination of two drugs, saxagliptin and metformin, which are used to treat type 2 diabetes. Recent studies have shown that patients who take saxagliptin-containing drugs like Kombiglyze XR may have an increased risk of heart failure and other Kombiglyze XR side effects. The exact reason for this link is not yet fully understood, but it is believed that saxagliptin may cause inflammation and fluid retention in the body, leading to heart failure and other Kombiglyze XR side effects.
Several clinical studies have been conducted to evaluate the safety of Kombiglyze XR in patients with type 2 diabetes. A 2016 study published in the Journal of Diabetes and its Complications compared the cardiovascular safety of Kombiglyze XR with metformin alone. The study found that there was no significant difference in the incidence of heart failure, myocardial infarction, or stroke between the two groups. If you suffered adverse health effects or Kombiglyze XR side effects callNashville Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit. Identifying patients who may be at higher risk of heart failure with Kombiglyze XR is crucial in ensuring their safety and minimizing the risk of potential adverse effects and Kombiglyze XR side effects. Patients with a history of heart failure, liver or kidney disease, or those taking medications that affect the cardiovascular system should be closely monitored when starting Kombiglyze XR therapy for Kombiglyze XR side effects. Additionally, older adults and those with pre-existing cardiovascular disease are also at increased risk of heart failure and other Kombiglyze XR side effects. Healthcare providers must evaluate patient medical histories and current medications before prescribing Kombiglyze XR to minimize the potential for adverse effects and Kombiglyze XR side effects. It is essential to keep in mind that not all patients will experience heart failure while taking Kombiglyze XR, but identifying high-risk individuals can help prevent potential complications. If patients have concerns about the potential risk of heart failure associated with Kombiglyze XR, there are alternative medications available to manage their diabetes. One option is to switch to a different class of medication such as metformin or a GLP-1 receptor agonist. Both of these medications have been shown to be effective in controlling blood sugar levels and have a lower risk of causing heart failure. Another option is to switch to an SGLT2 inhibitor, which has been shown to not only improve blood sugar control but also reduce the risk of heart failure and cardiovascular events. Patients should discuss their concerns with their healthcare provider who can help determine the best treatment plan based on individual needs and medical history. If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR Side Effects, specifically: heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation. nashville kombiglyze xr lawyer timothy l. milesTimothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, securities fraud, civil procedure, corporate formation, corporate takeover litigation, derivative lawsuits, and more. Visit out website. a closer look at the side effects of kombiglyze xr and by a nashville kombiglyze xr lawyer5/17/2023
If you took Kombiglyze XR and suffered Kombiglyze XR side effects call a Nashville Kombiglyze XR lawyer you may be eligible for a Kombiglyze XR lawsuit
Kombiglyze XR is a combination of metformin (a biguanide) and saxagliptin (a DPP4 inhibitor). Kombiglyze XR works by lowering the amount of sugar made by your liver, decreasing the amount of sugar absorbed by your intestine, increasing the amount of insulin your body makes, and helps your body respond better to insulin.
However, research shows that type 2 diabetes drug Kombiglyze XR (saxagliptin and metformin) may cause heart failure or other cardiovascular injuries in some patients. According to the Centers for Disease Control and Prevention (CDC), 30 million Americans have diabetes and 84 million have pre-diabetes. Metformin—one of the drugs found in combination in Kombiglyze—is among the top 10 most popular prescription drugs taken by Americans. Analysts also predict that Onglyza (saxagliptin), Kombiglyze’s sister drug, could reach $1.8 billion in sales in 2018. In 2015, roughly 386,000 people were prescribed Onglyza or Kombiglyze XR, the U.S. Food and Drug Administration (FDA) reported. Given that so many people take these drugs, any side effects they may cause that are severe enough to hospitalize patients should be treated with concern. Dozens of patients are filing lawsuits against Kombiglyze’s manufacturer AstraZeneca and its previous partner Bristol-Myers Squibb alleging that the companies failed to adequately test the drugs’ safety prior to selling it, which ultimately caused their cardiovascular injuries. If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation. Read on to learn more about the Kombiglyze XR side effects and see if you may be eligible for a Kombiglyze XR lawsuit if you suffered Kombiglyze side effects. WHAT ARE THE KOMBIGLYZE XR SIDE EFFECTS?
The following are some of the common Kombiglyze XR side effects:
Additionally, dozens of lawsuits allege other Kombiglyze XR side effects including serious cardiovascular injury. If you suffered Kombiglyze XR side effects call a Nashville Kombiglyze XR lawyer today. DOES KOMBIGLYZE XR PUT PATIENTS AT RISK OF HEART FAILURE?
A clinical trial funded by AstraZeneca and Bristol-Myers Squibb was one of the first studies to report cardiovascular health risks associated with these drugs.
Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus, or the SAVOR trial, found that patients with a history of heart problems who took Onglyza or Kombiglyze XR had a 27% greater chance of being hospitalized for heart failure than patients who took a placebo. Patients with chronic kidney disease and / or previous heart failure were more likely to be hospitalized. When an FDA panel reviewed the results from the SAVOR study, 14 out of 15 panelists voted to require a safety warning on all Onglyza and Kombiglyze XR bottles that the drugs could result in cardiovascular injury. Patients are filing lawsuits against AstraZeneca and Bristol-Myers Squibb alleging that Kombiglyze XR caused their cardiovascular injuries. Complaints allege that AstraZeneca and Bristol-Myers Squibb failed to adequately test the drug prior to their sale. In February 2018, more than 80 Onglyza and Kombiglyze XR lawsuits were centralized in Lexington, Kentucky. Plaintiffs' attorneys said that centralization is key to reducing inconsistencies since these lawsuits were "just the tip of the iceberg" and the number of filed complaints was expected to grow. In a complaint filed in January 2018, Illinois plaintiff Jerald Adams alleged that after being exposed to saxagliptin after taking both Onglyza and Kombiglyze XR, the diagnosis of his heart failure was “directly related to taking these drugs.” In the complaint, Mr. Adams alleged that the manufacturers not only knew of the cardiovascular injury risk associated with saxagliptin, but that they also failed to warn or mitigate this risk despite their knowledge including the Kombiglyze side effects. "At all relevant times, defendants had knowledge that there was a significantly increased risk of adverse events associated with saxagliptin, including heart failure, congestive heart failure, cardiac failure, and death related to those events, and despite this knowledge, defendants continued to manufacture, market, distribute, sell, and profit from sales of saxagliptin," the complaint alleges. Some lawsuits filed in New Jersey claim that Bristol-Myers and AstraZeneca did not just do a poor job of testing the safety of their drugs, but that they also did not conduct the clinical trials recommended by the FDA in 2008 prior to Onglyza’s sale debut in 2009. In 2008, the FDA Endocrinologic and Metabolic Drugs Advisory Committee "determined that concerns about cardiovascular risk should be more thoroughly addressed during drug development." Bristol-Myers and AstraZeneca failed to do so and began marketing Onglyza in 2009. HOW DO I KNOW IF I AM ELIGIBLE OR A KOMBIGLYZE XR LAWSUIT?
If you or a loved one took Kombiglyze XR as directed and suffered from heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, or other serious Kombiglyze XR side effects, after starting Kombiglyze XR therapy, you may meet the requirements for a Kombiglyze XR lawsuit and possibly be entitled to substantial compensation. Call a Nashville Kombiglyze XR lawyer for free today who can tell you if you are eligible for a Kombiglyze XR lawsuit.
IF I MEET THE REQUIREMENTS FOR A KOMBIGLYZE XR LAWSUIT, WHAT CAN I GET?
If you meet the requirements for a Kombiglyze XR lawsuit and are successful you can recover money for some of the following damages:
• Past and future medical bills (including medication, hospital stays, and in-home care) • Pain and suffering • Lost wages • Loss of earning capacity • Funeral expenses (in the event of a loved one’s death) Broadly speaking, a plaintiff who is eligible for a Kombiglyze XR lawsuit could be entitled to compensation for any past and future costs associated with their diagnosis if they meet the requirements for a Kombiglyze XR lawsuit and are successful. IF YOU SUFFERED FROM KOMBIGLYZE XR SIDE EFFECTS, CALL A NASHVILLE KOMBIGLYZE XR LAWYER TO SEE IF YOU ARE ELIGIBLE FOR A KOMBIGLYZE XR LAWSUIT
If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR Side Effects, specifically: heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation.
NASHVILLE KOMBIGLYZE XR LAWYER TIMOTHY L. MILESTimothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, securities fraud, civil procedure, corporate formation, corporate takeover litigation, derivative lawsuits, and more. Visit out website.
If you took Kombiglyze XR and suffered Kombiglyze XR side effects call a Nashville Kombiglyze XR lawyer you may be eligible for a Kombiglyze XR lawsuit
Kombiglyze XR is a combination of metformin (a biguanide) and saxagliptin (a DPP4 inhibitor). Kombiglyze XR works by lowering the amount of sugar made by your liver, decreasing the amount of sugar absorbed by your intestine, increasing the amount of insulin your body makes, and helps your body respond better to insulin.
However, research shows that type 2 diabetes drug Kombiglyze XR (saxagliptin and metformin) may cause heart failure or other cardiovascular injuries in some patients. According to the Centers for Disease Control and Prevention (CDC), 30 million Americans have diabetes and 84 million have pre-diabetes. Metformin—one of the drugs found in combination in Kombiglyze—is among the top 10 most popular prescription drugs taken by Americans. Analysts also predict that Onglyza (saxagliptin), Kombiglyze’s sister drug, could reach $1.8 billion in sales in 2018. In 2015, roughly 386,000 people were prescribed Onglyza or Kombiglyze XR, the U.S. Food and Drug Administration (FDA) reported. Given that so many people take these drugs, any side effects they may cause that are severe enough to hospitalize patients should be treated with concern. Dozens of patients are filing lawsuits against Kombiglyze’s manufacturer AstraZeneca and its previous partner Bristol-Myers Squibb alleging that the companies failed to adequately test the drugs’ safety prior to selling it, which ultimately caused their cardiovascular injuries. If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation. Read on for the answers to four frequently asked questions by Nashville Kombiglyze XR lawyer Timothy L. Miles about the Kombiglyze XR lawsuit and if you used Kombiglyze XR and suffered Kombiglyze XR side effects, see if you are eligible for a Kombiglyze XR lawsuit. WHAT ARE THE KOMBIGLYZE XR SIDE EFFECTS?
The following are some of the common Kombiglyze XR side effects:
Additionally, dozens of lawsuits allege other Kombiglyze XR side effects including serious cardiovascular injury. If you suffered Kombiglyze XR side effects call a Nashville Kombiglyze XR lawyer today. DOES KOMBIGLYZE XR PUT PATIENTS AT RISK OF HEART FAILURE?
A clinical trial funded by AstraZeneca and Bristol-Myers Squibb was one of the first studies to report cardiovascular health risks associated with these drugs and as another of the Kombiglyze XR side effects.
Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus, or the SAVOR trial, found that patients with a history of heart problems who took Onglyza or Kombiglyze XR had a 27% greater chance of being hospitalized for heart failure than patients who took a placebo. Patients with chronic kidney disease and / or previous heart failure were more likely to be hospitalized. When an FDA panel reviewed the results from the SAVOR study, 14 out of 15 panelists voted to require a safety warning on all Onglyza and Kombiglyze XR bottles that the drugs could result in cardiovascular injury. Patients are filing lawsuits against AstraZeneca and Bristol-Myers Squibb alleging that Kombiglyze XR caused their cardiovascular injuries. Complaints allege that AstraZeneca and Bristol-Myers Squibb failed to adequately test the drug prior to their sale and did not disclose the Kombiglyze XR side effects. In February 2018, more than 80 Onglyza and Kombiglyze XR lawsuits were centralized in Lexington, Kentucky. Plaintiffs' attorneys said that centralization is key to reducing inconsistencies since these lawsuits were "just the tip of the iceberg" and the number of filed complaints was expected to grow. In a complaint filed in January 2018, Illinois plaintiff Jerald Adams alleged that after being exposed to saxagliptin after taking both Onglyza and Kombiglyze XR, the diagnosis of his heart failure was “directly related to taking these drugs.” In the complaint, Mr. Adams alleged that the manufacturers not only knew of the cardiovascular injury risk associated with saxagliptin, but that they also failed to warn or mitigate this risk despite their knowledge. "At all relevant times, defendants had knowledge that there was a significantly increased risk of adverse events associated with saxagliptin, including heart failure, congestive heart failure, cardiac failure, and death related to those events, and despite this knowledge, defendants continued to manufacture, market, distribute, sell, and profit from sales of saxagliptin," the complaint alleges. Some lawsuits filed in New Jersey claim that Bristol-Myers and AstraZeneca did not just do a poor job of testing the safety of their drugs, but that they also did not conduct the clinical trials recommended by the FDA in 2008 prior to Onglyza’s sale debut in 2009. In 2008, the FDA Endocrinologic and Metabolic Drugs Advisory Committee "determined that concerns about cardiovascular risk should be more thoroughly addressed during drug development." Bristol-Myers and AstraZeneca failed to do so and began marketing Onglyza in 2009. HOW DO I KNOW IF I AM ELIGIBLE OR A KOMBIGLYZE XR LAWSUIT?
If you or a loved one took Kombiglyze XR as directed and suffered from heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, or other serious Kombiglyze side effects after starting Kombiglyze XR therapy, you may meet the requirements for a Kombiglyze XR lawsuit and possibly be entitled to substantial compensation. Call a Nashville Kombiglyze XR lawyer for free today who can tell you if you are eligible for a Kombiglyze XR lawsuit.
IF I MEET THE REQUIREMENTS FOR A KOMBIGLYZE XR LAWSUIT, WHAT CAN I GET?
If you meet the requirements for a Kombiglyze XR lawsuit and are successful you can recover money for some of the following damages:
• Past and future medical bills (including medication, hospital stays, and in-home care) • Pain and suffering • Lost wages • Loss of earning capacity • Funeral expenses (in the event of a loved one’s death) Broadly speaking, a plaintiff who is eligible for a Kombiglyze XR lawsuit could be entitled to compensation for any past and future costs associated with their diagnosis if they meet the requirements for a Kombiglyze XR lawsuit and are successful. IF YOU SUFFERED FROM KOMBIGLYZE XR SIDE EFFECTS, CALL A NASHVILLE KOMBIGLYZE XR LAWYER TO SEE IF YOU ARE ELIGIBLE FOR A KOMBIGLYZE XR LAWSUIT
If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR Side Effects, specifically: heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation.
nashville kombiglyze xr lawyer timothy l. miles, esq.Timothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, securities fraud, civil procedure, corporate formation, corporate takeover litigation, derivative lawsuits, and more. Visit out website.
If you took Kombiglyze XR and suffered from Kombiglyze XR side effects contact Nashville Kombiglyze XR lawyer Timothy L. Miles today
Kombiglyze XR is a combination of metformin (a biguanide) and saxagliptin (a DPP4 inhibitor). Kombiglyze XR works by lowering the amount of sugar made by your liver, decreasing the amount of sugar absorbed by your intestine, increasing the amount of insulin your body makes, and helps your body respond better to insulin.
However, research shows that type 2 diabetes drug Kombiglyze XR (saxagliptin and metformin) may cause heart failure or other cardiovascular injuries in some patients. According to the Centers for Disease Control and Prevention (CDC), 30 million Americans have diabetes and 84 million have pre-diabetes. Metformin—one of the drugs found in combination in Kombiglyze—is among the top 10 most popular prescription drugs taken by Americans. Analysts also predict that Onglyza (saxagliptin), Kombiglyze’s sister drug, could reach $1.8 billion in sales in 2018. In 2015, roughly 386,000 people were prescribed Onglyza or Kombiglyze XR, the U.S. Food and Drug Administration (FDA) reported. Given that so many people take these drugs, any side effects they may cause that are severe enough to hospitalize patients should be treated with concern. Dozens of patients are filing lawsuits against Kombiglyze’s manufacturer AstraZeneca and its previous partner Bristol-Myers Squibb alleging that the companies failed to adequately test the drugs’ safety prior to selling it, which ultimately caused their cardiovascular injuries. If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today for a free case evaluation to see if you meet the requirements for a Kombiglyze XR lawsuit are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation. Read on to learn more about the requirements for a Kombiglyze XR lawsuit and who is eligible for a Kombiglyze XR lawsuit by Nashville Kombiglyze XR lawyer Timothy L. Miles. Please visit our full Kombiglyze XR page on our website by clicking here. WHAT ARE THE KOMBIGLYZE XR SIDE EFFECTS?
The following are some of the common Kombiglyze XR side effects:
Additionally, dozens of lawsuits allege other Kombiglyze XR side effects including serious cardiovascular injury. DOES KOMBIGLYZE XR PUT PATIENTS AT RISK OF HEART FAILURE?
A clinical trial funded by AstraZeneca and Bristol-Myers Squibb was one of the first studies to report cardiovascular health risks associated with these drugs as another of the Kombiglyze XR side effects.
Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus, or the SAVOR trial, found that patients with a history of heart problems who took Onglyza or Kombiglyze XR had a 27% greater chance of being hospitalized for heart failure than patients who took a placebo. Patients with chronic kidney disease and / or previous heart failure were more likely to be hospitalized. When an FDA panel reviewed the results from the SAVOR study, 14 out of 15 panelists voted to require a safety warning on all Onglyza and Kombiglyze XR bottles that the drugs could result in cardiovascular injury as another one of the Kombiglyze XR side effects. Patients are filing lawsuits against AstraZeneca and Bristol-Myers Squibb alleging that Kombiglyze XR caused their cardiovascular injuries. Complaints allege that AstraZeneca and Bristol-Myers Squibb failed to adequately test the drug prior to their sale. In February 2018, more than 80 Onglyza and Kombiglyze XR lawsuits were centralized in Lexington, Kentucky. Plaintiffs' attorneys said that centralization is key to reducing inconsistencies since these lawsuits were "just the tip of the iceberg" and the number of filed complaints was expected to grow. In a complaint filed in January 2018, Illinois plaintiff Jerald Adams alleged that after being exposed to saxagliptin after taking both Onglyza and Kombiglyze XR, the diagnosis of his heart failure was “directly related to taking these drugs.” In the complaint, Mr. Adams alleged that the manufacturers not only knew of the cardiovascular injury risk associated with saxagliptin, but that they also failed to warn or mitigate this risk despite their knowledge. "At all relevant times, defendants had knowledge that there was a significantly increased risk of adverse events associated with saxagliptin, including heart failure, congestive heart failure, cardiac failure, and death related to those events, and despite this knowledge, defendants continued to manufacture, market, distribute, sell, and profit from sales of saxagliptin," the complaint alleges. Some lawsuits filed in New Jersey claim that Bristol-Myers and AstraZeneca did not just do a poor job of testing the safety of their drugs, but that they also did not conduct the clinical trials recommended by the FDA in 2008 prior to Onglyza’s sale debut in 2009. In 2008, the FDA Endocrinologic and Metabolic Drugs Advisory Committee "determined that concerns about cardiovascular risk should be more thoroughly addressed during drug development." Bristol-Myers and AstraZeneca failed to do so and began marketing Onglyza in 2009. HOW DO I KNOW IF I AM ELIGIBLE fOR A KOMBIGLYZE XR LAWSUIT?
If you or a loved one took Kombiglyze XR as directed and suffered from heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, or other serious Kombiglyze XR side effects after starting Kombiglyze XR therapy, you may meet the requirements for a Kombiglyze XR lawsuit and possibly be entitled to substantial compensation. Call a Nashville Kombiglyze XR lawyer for free today who can tell you if you are eligible for a Kombiglyze XR lawsuit.
IF I MEET THE REQUIREMENTS FOR A KOMBIGLYZE XR LAWSUIT, WHAT CAN I GET?
If you meet the requirements for a Kombiglyze XR lawsuit and are successful you can recover money for some of the following damages:
• Past and future medical bills (including medication, hospital stays, and in-home care) • Pain and suffering • Lost wages • Loss of earning capacity • Funeral expenses (in the event of a loved one’s death) Broadly speaking, a plaintiff who is eligible for a Kombiglyze XR lawsuit could be entitled to compensation for any past and future costs associated with their diagnosis if they meet the requirements for a Kombiglyze XR lawsuit and are successful. WHAT CAN A NASHVILLE KOMBIGLYZE XR LAWYER DO FOR ME IF I AM ELIGIBLE FOR A KOMBIGLYZE XR LAWSUIT?
Because of the complexity of the cases and the need to hire experts, a products liability attorney is the go-to attorney when you have been injured by a drug or a product that is defective like Kombiglyze XR. A Nashville Kombiglyze XR Lawyer, who is an experienced products liability attorney, can help you by putting you in the best possible position to win your Kombiglyze XR Lawsuit and recover the most compensation if you are eligible for a Kombiglyze XR lawsuit.
HOW DOES A KOMBIGLYZE XR LAWSUIT WORK?
If you meet the requirements for a Kombiglyze XR lawsuit, before it is filed with the court, your Nashville Kombiglyze XR lawyer will fully explain the process and will then need to ask you a few questions concerning the circumstances of you diagnoses, how long you have been taking Kombiglyze XR and your medical history including you Kombiglyze XR side effects.
Your Nashville Kombiglyze XR lawyer will then draft what is known as a complaint. This will be a multi-page document explaining why the defendant is responsible for your injuries and what damages (that is, compensation) you are seeking. Once your complaint is filed with the court, your Kombiglyze XR Lawsuit officially begins. From here, it will be a lot of back and forth between your Nashville Kombiglyze XR lawyer and the attorney(s) for the defendant in an attempt to resolve the matter. The attorneys may take review documents, take depositions, issue subpoenas, hire experts, calculate damages, attend hearings, and file motions, briefs, evidence or other documents with the court during the stages of the lawsuit. If your Kombiglyze XR lawsuit. is not dismissed and a settlement cannot be reached, the case will proceed to a jury trial. IF YOU SUFFERED FROM KOMBIGLYZE XR SIDE EFFECTS, CALL A NASHVILLE KOMBIGLYZE XR LAWYER TO SEE IF YOU ARE ELIGIBLE FOR A KOMBIGLYZE XR LAWSUIT
If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR Side Effects, specifically: heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Nashville Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation.
nashville kombiglyze xr lawyer timothy l. miles, esq.Timothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, securities fraud, civil procedure, corporate formation, corporate takeover litigation, derivative lawsuits, and more. Visit out website. Kombiglyze XR is a combination of metformin (a biguanide) and saxagliptin (a DPP4 inhibitor). Kombiglyze XR works by lowering the amount of sugar made by your liver, decreasing the amount of sugar absorbed by your intestine, increasing the amount of insulin your body makes, and helps your body respond better to insulin. However, research shows that type 2 diabetes drug Kombiglyze XR (saxagliptin and metformin) may cause heart failure or other cardiovascular injuries in some patients. According to the Centers for Disease Control and Prevention (CDC), 30 million Americans have diabetes and 84 million have pre-diabetes. Metformin—one of the drugs found in combination in Kombiglyze—is among the top 10 most popular prescription drugs taken by Americans. Analysts also predict that Onglyza (saxagliptin), Kombiglyze’s sister drug, could reach $1.8 billion in sales in 2018. In 2015, roughly 386,000 people were prescribed Onglyza or Kombiglyze XR, the U.S. Food and Drug Administration (FDA) reported. Given that so many people take these drugs, any side effects they may cause that are severe enough to hospitalize patients should be treated with concern. Dozens of patients are filing lawsuits against Kombiglyze’s manufacturer AstraZeneca and its previous partner Bristol-Myers Squibb alleging that the companies failed to adequately test the drugs’ safety prior to selling it, which ultimately caused their cardiovascular injuries. If you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR side effects including heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Kombiglyze XR lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation. Read on for answers to five frequently asked questions about a Kombiglyze lawsuit and see if you are eligible for a Kombiglyze XR lawsuit. WHAT ARE THE KOMBIGLYZE XR SIDE EFFECTS?The following are some of the common Kombiglyze XR side effects:
Additionally, dozens of lawsuits allege other Kombiglyze XR side effects including serious cardiovascular injury. If you suffered serious Kombiglyze XR side effects call Kombiglyze lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit. WHAT IS THE PROBLEM WITH KOMBIGLYZE XR?Research shows Kombiglyze XR and other similar drugs may put patients at risk of heart complications. Dozens of patients are filing lawsuits against Kombiglyze’s manufacturer AstraZeneca and its previous partner Bristol-Myers Squibb alleging that the companies failed to adequately test the drugs’ safety prior to selling it, which ultimately caused their cardiovascular injuries. If you suffered cardiovascular injuries after taking Kombiglyze or other serious Kombiglyze XR side effects call Kombiglyze lawyer Timothy L. Miles today for a free case evaluation to see if you are eligible for a Kombiglyze XR lawsuit. DOES KOMBIGLYZE XR PUT PATIENTS AT RISK OF HEART FAILURE?A clinical trial funded by AstraZeneca and Bristol-Myers Squibb was one of the first studies to report cardiovascular health risks associated with these drugs. Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus, or the SAVOR trial, found that patients with a history of heart problems who took Onglyza or Kombiglyze XR had a 27% greater chance of being hospitalized for heart failure than patients who took a placebo. Patients with chronic kidney disease and / or previous heart failure were more likely to be hospitalized. When an FDA panel reviewed the results from the SAVOR study, 14 out of 15 panelists voted to require a safety warning on all Onglyza and Kombiglyze XR bottles that the drugs could result in cardiovascular injury. Patients are filing lawsuits against AstraZeneca and Bristol-Myers Squibb alleging that Kombiglyze XR caused their cardiovascular injuries. Complaints allege that AstraZeneca and Bristol-Myers Squibb failed to adequately test the drug prior to their sale. In February 2018, more than 80 Onglyza and Kombiglyze XR lawsuits were centralized in Lexington, Kentucky. Plaintiffs' attorneys said that centralization is key to reducing inconsistencies since these lawsuits were "just the tip of the iceberg" and the number of filed complaints was expected to grow. In a complaint filed in January 2018, Illinois plaintiff Jerald Adams alleged that after being exposed to saxagliptin after taking both Onglyza and Kombiglyze XR, the diagnosis of his heart failure was “directly related to taking these drugs.” In the complaint, Mr. Adams alleged that the manufacturers not only knew of the cardiovascular injury risk associated with saxagliptin, but that they also failed to warn or mitigate this risk despite their knowledge. "At all relevant times, defendants had knowledge that there was a significantly increased risk of adverse events associated with saxagliptin, including heart failure, congestive heart failure, cardiac failure, and death related to those events, and despite this knowledge, defendants continued to manufacture, market, distribute, sell, and profit from sales of saxagliptin," the complaint alleges. Some lawsuits filed in New Jersey claim that Bristol-Myers and AstraZeneca did not just do a poor job of testing the safety of their drugs, but that they also did not conduct the clinical trials recommended by the FDA in 2008 prior to Onglyza’s sale debut in 2009. In 2008, the FDA Endocrinologic and Metabolic Drugs Advisory Committee "determined that concerns about cardiovascular risk should be more thoroughly addressed during drug development." Bristol-Myers and AstraZeneca failed to do so and began marketing Onglyza in 2009. WHAT DO THE KOMBIGLYZE XR LAWSUITS ALLEGE?Kombiglyze XR lawsuits allege that AstraZeneca and Bristol-Myers Squibb failed to:
HOW DO I KNOW IF I AM ELIGIBLE OR A KOMBIGLYZE XR LAWSUIT?If you or a loved one took Kombiglyze XR as directed and suffered from heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, you may meet the requirements for a Kombiglyze XR lawsuit and possibly be entitled to substantial compensation. Call a Kombiglyze XR lawyer for free today who can tell you if you are eligible for a Kombiglyze XR lawsuit. IF YOU SUFFERED FROM KOMBIGLYZE XR SIDE EFFECTS, CALL A KOMBIGLYZE XR LAWYER TO SEE IF YOU ARE ELIGIBLE FOR A KOMBIGLYZE XR LAWSUITIf you or a loved one took Kombiglyze XR as directed and suffered from Kombiglyze XR Side Effects, specifically: heart failure or other cardiovascular injuries—such as congestive heart failure or myocardial infarction, after starting Kombiglyze XR therapy, contact Kombiglyze XR lawyer Timothy L. Miles today to see if you are eligible for a Kombiglyze XR lawsuit and possibly entitled to substantial compensation. TIMOTHY L. MILES, ESQ.Timothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, securities fraud, civil procedure, corporate formation, corporate takeover litigation, derivative lawsuits, and more. Visit out website. |
CONTACT
The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: [email protected] HOURS OF OPERATION Mon-Fri: 24/7 Sat-Sun: 24/7 |
CONNECt FacebooK
|